Novo Nordisk announced that NovoPen Echo is now available. NovoPen Echo is the first insulin pen device available with half-unit dosing and a memory function that records the dose and elapsed time.

RELATED: Endocrine Disorders Resource Center

Half-unit dose increments allow for more detailed adjustments, which can be particularly important for the pediatric population. Other key features include an easy-to-use dial that will not select more units than left in the cartridge, an end-of-dose click, a short button travel to ease self-injections, and an easy to change Penfill cartridge.

NovoPen Echo will be available to patients for use with NovoLog (insulin aspart [rDNA origin] injection) PenFill cartridges. Also, different removable skins will be available for a kid-friendly customized look.

For more information call (800) 727-6500 or visit Novonordisk-US.com.